Intuitive Surgical, Inc. (ISRG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for ...

Why Intuitive Surgical stock is on investors’ radar today Intuitive Surgical (ISRG) is drawing attention after a period of ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve ...

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and $2.53 EPS.

Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly. The flywheel of Intuitive Surgical's ...